DGIdb - LEVOMEPROMAZINE Drug Record

LEVOMEPROMAZINE CHEMBL1764 FDA Approved

Alternate Names:

Levomepromazine
Methotrimeprazine
Levoprome
RP-7044
XP03
Tisercin
Nirvan
CL-39743
CL-36467
SK&F-5116
Riva-meprazine 5mg Tablets
Riva-meprazine 50mg Tablets
Riva-meprazine 25mg Tablets
PMS-methotrimeprazine
Nozinan Tab 50mg
Nozinan Tab 2mg
Nozinan Tab 25mg
Nozinan Liq 40mg/ml
Nozinan Inj 25mg/ml
Nozinan 5mg/ml
Nozinan 5mg Tab
Nozinan
Novo Meprazine Tab 5mg
Novo Meprazine Tab 25mg
Nov Meprazine Tab 50mg
Nosinan
Neurocil
Methotrimeprazine-50
Methotrimeprazine-5
Methotrimeprazine-25
Methotrimeprazine-2
Methoprazine
60-99-1
Levomepromazinum
Levomepromazina
2-Methoxytrimeprazine
(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine
(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
DB01403
10H-PHENOTHIAZINE-10-PROPANAMINE, 2-METHOXY-N,N,B-TRIMETHYL-, (.BETA.R)-
(R)-(-)-2-METHOXY-N,N,BETA-TRIMETHYL-10H-PHENOTHIAZINE-10-PROPANAMINE
(2R)-3-(2-METHOXYPHENOTHIAZIN-10-YL)-N,N,2-TRIMETHYL-PROPAN-1-AMINE
LEVOMEPRAZINE\|\|\|LEVOMEPROMAZIN\|\|\|LEVOPROMEHAZINE\|\|\|NEOZINE\|\|\|NIRVAN
D00403
C07192
AB00514679
PL061791
PL006275
NCGC00179370-01
LEVOMEPROMAZINE [USAN:INN:BAN:DCF]
BDBM50418049
ZINC20246
PHENOTHIAZINE, 10-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-2-METHOXY-, (-)-
10H-PHENOTHIAZINE-10-PROPANAMINE, 2-METHOXY-N,N,BETA-TRIMETHYL-, (R)-
10H-PHENOTHIAZINE-10-PROPANAMINE, 2-METHOXY-N,N,BETA-TRIMETHYL-, (BETAR)-
10H-PHENOTHIAZINE-10-PROPANAMINE, 2-METHOXY-N,N,BETA-TRIMETHYL-, (-)-
GTPL7603
BPBIO1_001028
SPBIO_002873
BSPBIO_000934
SCHEMBL25462
LEVOMEPROMAZINE (USAN/INN)
AC1Q57ZP
AC1L2HS7
9G0LAW7ATQ
PRESTWICK3_000797
PRESTWICK2_000797
PRESTWICK1_000797
PRESTWICK0_000797
7104-38-3
LEVOPROME (TN)
7044 R.P.
CL 53212
[(2R)-3-(2-METHOXY-10H-PHENOTHIAZIN-10-YL)-2-METHYLPROPYL]DIMETHYLAMINE
NSC 226516
NSC226516
EINECS 200-495-5
NOZINANREG
NOSINANREG
LEVOPROMEREG
LEVOMEPROMAZINA [INN-SPANISH]
LEVOMEPROMAZINUM [INN-LATIN]
ARC-VI-C-5
BAYER 1213
CL 39743
CL 36467
(2R)-3-(2-METHOXY-10H-PHENOTHIAZIN-10-YL)-N,N,2-TRIMETHYLPROPAN-1-AMINE
(2R)-3-(2-METHOXYPHENOTHIAZIN-10-YL)-N,N,2-TRIMETHYLPROPAN-1-AMINE
METHOXYTRIMEPRAZINE
VERACTIL
NOMIZAN
NOCINAN
NIRNAMINE
LEVOTOMIN
HIRNAMINE
DEDORAN
LEVOPROMAZIONI
METHOTRIMEPRAZINE [USP]
METHOTRIMEPRAZINE (USP)
MINOZINAN
MILEZIN
CHEBI:6838
NEOZINE
UNII-9G0LAW7ATQ
72287

Drug Info:

FDA Approval	not approved by the FDA
Drug Class	small molecule
Drug Indications	Antipsychotic Agents
Year of Approval	not approved by the fda
Drug Class	antipsychotic agents
Drug Categories	tranquilizing agents
Drug Categories	therapeutic uses
Drug Categories	sulfur compounds
Drug Categories	sensory system agents
Drug Categories	qtc-prolonging agents (indeterminate risk and risk modifying)
Drug Categories	psychotropic drugs
Drug Categories	psycholeptics
Drug Categories	physiological effects of drugs
Drug Categories	phenothiazines with aliphatic side-chain
Drug Categories	phenothiazines
Drug Categories	pharmacologic actions
Drug Categories	peripheral nervous system agents
Drug Categories	organic chemicals
Drug Categories	neurotransmitter agents
Drug Categories	nervous system
Drug Categories	molecular mechanisms of pharmacological action
Drug Categories	inorganic chemicals
Drug Categories	hyperglycemia-associated agents
Drug Categories	heterocyclic compounds, 3-ring
Drug Categories	heterocyclic compounds
Drug Categories	dopamine antagonists
Drug Categories	dopamine agents
Drug Categories	cytochrome p-450 cyp2e1 inhibitors
Drug Categories	cytochrome p-450 cyp2d6 substrates
Drug Categories	cytochrome p-450 cyp2d6 inhibitors (strong)
Drug Categories	cytochrome p-450 cyp2d6 inhibitors
Drug Categories	cytochrome p-450 cyp1a2 inhibitors
Drug Categories	chemical actions and uses
Drug Categories	central nervous system depressants
Drug Categories	central nervous system agents
Drug Categories	antipsychotic agents (first generation [typical])
Drug Categories	antipsychotic agents
Drug Categories	analgesics, non-narcotic
Drug Categories	analgesics
Drug Categories	alpha1 antagonists
Drug Groups	approved
Drug Type	small molecule

(1 More Sources)

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.
Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin
Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.
Tsukamoto et al., 1984, Interaction of neuroleptics and antidepressants with rat brain alpha 2-receptors: a possible relationship between alpha 2-receptor antagonism and antidepressant action., Biol. Psychiatry

LEVOMEPROMAZINE DRD3

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Mechanism of Interaction D2-like dopamine receptor antagonist

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

LEVOMEPROMAZINE DRD2

Interaction Types:

antagonist

Interaction Info:

Mechanism of Interaction D2-like dopamine receptor antagonist

Direct Interaction yes

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.

LEVOMEPROMAZINE DRD1

Interaction Types:

antagonist

Interaction Info:

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin
LEVOMEPROMAZINE DRD5

Interaction Types:

antagonist

Interaction Info:

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin
LEVOMEPROMAZINE DRD4

Interaction Types:

antagonist

Interaction Info:

Mechanism of Interaction D2-like dopamine receptor antagonist

Direct Interaction yes

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin
LEVOMEPROMAZINE HTR2A

Interaction Types:

antagonist

Interaction Info:

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin
LEVOMEPROMAZINE HTR2C

Interaction Types:

antagonist

Interaction Info:

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin
LEVOMEPROMAZINE HRH1

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

LEVOMEPROMAZINE CHRM1

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

LEVOMEPROMAZINE CHRM2

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

LEVOMEPROMAZINE CHRM3

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

LEVOMEPROMAZINE CHRM4

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

LEVOMEPROMAZINE CHRM5

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

LEVOMEPROMAZINE ADRA1A

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

LEVOMEPROMAZINE ADRA1B

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

LEVOMEPROMAZINE ADRA1D

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

LEVOMEPROMAZINE ADRA2A

Interaction Types:

antagonist

Interaction Info:

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Tsukamoto et al., 1984, Interaction of neuroleptics and antidepressants with rat brain alpha 2-receptors: a possible relationship between alpha 2-receptor antagonism and antidepressant action., Biol. Psychiatry

LEVOMEPROMAZINE ADRA2B

Interaction Types:

antagonist

Interaction Info:

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Tsukamoto et al., 1984, Interaction of neuroleptics and antidepressants with rat brain alpha 2-receptors: a possible relationship between alpha 2-receptor antagonism and antidepressant action., Biol. Psychiatry

LEVOMEPROMAZINE ADRA2C

Interaction Types:

antagonist

Interaction Info:

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Tsukamoto et al., 1984, Interaction of neuroleptics and antidepressants with rat brain alpha 2-receptors: a possible relationship between alpha 2-receptor antagonism and antidepressant action., Biol. Psychiatry

LEVOMEPROMAZINE HTR2B

Interaction Types:

n/a

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

DrugBank: DB01403

Version: 5.0.8

Alternate Names:

METHOTRIMEPRAZINE DrugBank Drug Name

(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine Drug Synonym

(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine Drug Synonym

Drug Info:

Drug Type small molecule

Drug Groups approved

Drug Categories alpha1 antagonists

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

TEND: METHOTRIMEPRAZINE
- Version: 01-August-2011
Alternate Names:

METHOTRIMEPRAZINE Primary Drug Name

Drug Info:

Drug Class antipsychotic agents

Year of Approval not approved by the fda

Publications:
TdgClinicalTrial: METHOTRIMEPRAZINE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications Antipsychotic Agents

Drug Class small molecule

FDA Approval not approved by the FDA

Publications:
PubChem: LEVOMEPROMAZINE
- Version: 09-Feb-2016
Alternate Names:

LEVOMEPROMAZINE pubchem_primary_name

72287 PubChem CID

METHOTRIMEPRAZINE Drug Synonym

Drug Info:

Publications:
ChemblInteractions: CHEMBL1764
- Version: chembl_23
Alternate Names:

Drug Info:

Publications:

Trial Name	-
Novel drug target	Established target
Mechanism of Interaction	D2-like dopamine receptor antagonist

Mechanism of Interaction	D2-like dopamine receptor antagonist
Direct Interaction	yes

METHOTRIMEPRAZINE	DrugBank Drug Name
(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine	Drug Synonym
(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine	Drug Synonym

LEVOMEPROMAZINE	pubchem_primary_name
72287	PubChem CID
METHOTRIMEPRAZINE	Drug Synonym

LEVOMEPROMAZINE Drug Record

LEVOMEPROMAZINE CHEMBL1764 FDA Approved

Alternate Names:

Drug Info:

Publications:

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target Mechanism of Interaction D2-like dopamine receptor antagonist

Publications: Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info: Mechanism of Interaction D2-like dopamine receptor antagonist Direct Interaction yes

Interaction Types: antagonist

Interaction Info:

Publications: Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info:

Publications: Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info: Mechanism of Interaction D2-like dopamine receptor antagonist Direct Interaction yes

Publications: Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info:

Publications: Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info:

Publications: Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Publications: Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Publications: Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol. Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Publications: Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol. Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info: Trial Name - Novel drug target Established target

Publications: Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol. Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types: antagonist

Interaction Info:

Interaction Types: antagonist

Interaction Info:

Interaction Types: antagonist

Interaction Info:

Interaction Types: n/a

Interaction Info: Trial Name - Novel drug target Established target

Publications:

DrugBank: DB01403

Alternate Names: METHOTRIMEPRAZINE DrugBank Drug Name (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine Drug Synonym (-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine Drug Synonym

Drug Info: Drug Type small molecule Drug Groups approved Drug Categories alpha1 antagonists

TEND: METHOTRIMEPRAZINE

Alternate Names: METHOTRIMEPRAZINE Primary Drug Name

Drug Info: Drug Class antipsychotic agents Year of Approval not approved by the fda

Publications:

TdgClinicalTrial: METHOTRIMEPRAZINE

Alternate Names:

Drug Info: Drug Indications Antipsychotic Agents Drug Class small molecule FDA Approval not approved by the FDA

Publications:

PubChem: LEVOMEPROMAZINE

Alternate Names: LEVOMEPROMAZINE pubchem_primary_name 72287 PubChem CID METHOTRIMEPRAZINE Drug Synonym

Drug Info:

Publications:

ChemblInteractions: CHEMBL1764

Alternate Names:

Drug Info:

Publications:

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Mechanism of Interaction D2-like dopamine receptor antagonist

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Interaction Info:

Mechanism of Interaction D2-like dopamine receptor antagonist

Direct Interaction yes

Interaction Types:

antagonist

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Interaction Info:

Mechanism of Interaction D2-like dopamine receptor antagonist

Direct Interaction yes

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Publications:

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Hals et al., 1988, Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites., Life Sci.

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Interaction Info:

Trial Name -

Novel drug target Established target

Publications:

Dahl et al., 1986, Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding., Biochem. Pharmacol.

Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin

Interaction Types:

antagonist

Interaction Types:

antagonist

Interaction Types:

antagonist

Interaction Types:

n/a

Interaction Info:

Trial Name -

Novel drug target Established target

Alternate Names:

METHOTRIMEPRAZINE DrugBank Drug Name

(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine Drug Synonym

(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine Drug Synonym

Drug Info:

Drug Type small molecule

Drug Groups approved

Drug Categories alpha1 antagonists

Alternate Names:

METHOTRIMEPRAZINE Primary Drug Name

Drug Info:

Drug Class antipsychotic agents

Year of Approval not approved by the fda

Drug Info:

Drug Indications Antipsychotic Agents

Drug Class small molecule

FDA Approval not approved by the FDA

Alternate Names:

LEVOMEPROMAZINE pubchem_primary_name

72287 PubChem CID

METHOTRIMEPRAZINE Drug Synonym